Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3305099373;99374;99375 chr2:178538681;178538680;178538679chr2:179403408;179403407;179403406
N2AB3140994450;94451;94452 chr2:178538681;178538680;178538679chr2:179403408;179403407;179403406
N2A3048291669;91670;91671 chr2:178538681;178538680;178538679chr2:179403408;179403407;179403406
N2B2398572178;72179;72180 chr2:178538681;178538680;178538679chr2:179403408;179403407;179403406
Novex-12411072553;72554;72555 chr2:178538681;178538680;178538679chr2:179403408;179403407;179403406
Novex-22417772754;72755;72756 chr2:178538681;178538680;178538679chr2:179403408;179403407;179403406
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: K
  • RefSeq wild type transcript codon: AAG
  • RefSeq wild type template codon: TTC
  • Domain: Fn3-129
  • Domain position: 53
  • Structural Position: 70
  • Q(SASA): 0.527
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
K/M rs780650379 None 1.0 N 0.696 0.459 0.403609169532 gnomAD-4.0.0 4.7896E-06 None None None None N None 0 0 None 0 0 None 0 0 6.29649E-06 0 0
K/N None None 0.999 N 0.677 0.179 0.212008924253 gnomAD-4.0.0 3.60099E-06 None None None None N None 0 0 None 0 0 None 0 0 3.93753E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
K/A 0.3554 ambiguous 0.4161 ambiguous 0.057 Stabilizing 0.997 D 0.565 neutral None None None None N
K/C 0.788 likely_pathogenic 0.8335 pathogenic -0.399 Destabilizing 1.0 D 0.763 deleterious None None None None N
K/D 0.5368 ambiguous 0.5837 pathogenic -0.261 Destabilizing 1.0 D 0.675 prob.neutral None None None None N
K/E 0.2041 likely_benign 0.225 benign -0.272 Destabilizing 0.992 D 0.477 neutral N 0.42454992 None None N
K/F 0.8556 likely_pathogenic 0.8904 pathogenic -0.267 Destabilizing 1.0 D 0.715 prob.delet. None None None None N
K/G 0.3912 ambiguous 0.4633 ambiguous -0.078 Destabilizing 1.0 D 0.623 neutral None None None None N
K/H 0.4004 ambiguous 0.4516 ambiguous -0.191 Destabilizing 1.0 D 0.699 prob.neutral None None None None N
K/I 0.5099 ambiguous 0.5507 ambiguous 0.33 Stabilizing 1.0 D 0.738 prob.delet. None None None None N
K/L 0.4572 ambiguous 0.5179 ambiguous 0.33 Stabilizing 1.0 D 0.623 neutral None None None None N
K/M 0.3549 ambiguous 0.4019 ambiguous -0.043 Destabilizing 1.0 D 0.696 prob.neutral N 0.50316542 None None N
K/N 0.4541 ambiguous 0.5044 ambiguous 0.056 Stabilizing 0.999 D 0.677 prob.neutral N 0.464684389 None None N
K/P 0.5563 ambiguous 0.6365 pathogenic 0.263 Stabilizing 1.0 D 0.705 prob.neutral None None None None N
K/Q 0.1532 likely_benign 0.1733 benign -0.087 Destabilizing 0.957 D 0.299 neutral N 0.447773497 None None N
K/R 0.0878 likely_benign 0.0962 benign -0.076 Destabilizing 0.996 D 0.509 neutral N 0.464511031 None None N
K/S 0.4095 ambiguous 0.4619 ambiguous -0.305 Destabilizing 0.997 D 0.569 neutral None None None None N
K/T 0.196 likely_benign 0.2179 benign -0.198 Destabilizing 0.999 D 0.681 prob.neutral N 0.412524773 None None N
K/V 0.4432 ambiguous 0.4849 ambiguous 0.263 Stabilizing 1.0 D 0.685 prob.neutral None None None None N
K/W 0.809 likely_pathogenic 0.8556 pathogenic -0.371 Destabilizing 1.0 D 0.777 deleterious None None None None N
K/Y 0.7407 likely_pathogenic 0.789 pathogenic -0.014 Destabilizing 1.0 D 0.726 prob.delet. None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.